Application Note: An optimized protocol for the 2 mg/well Clarity OXT format plates
15 September 2023

In this application note from Phenomenex, explore how oligonucleotides are becoming increasingly prominent in modern medicine due to their ability to modulate both gene expression and post-transcriptional splicing of introns and exons. Discover how the Spinraza®, a typical 2'-MOE-Gapmer chemistry antisense oligonucleotide, is being used in a new optimized protocol using the Clarity® OXT format plates.